A facile synthesis of a novel family of heterotricyclic hybrids: Spiro-pyrrolopyridazines

References

• (a) Maes, B. U. W.; Lemiere, G. L. F. Pyridazines and their Benzo Derivatives. In Comprehensive Heterocyclic Chemistry III; Katritzky, A. R.; Ramsden, C. A.; Scriven, E. F. V.; Taylor, R. J. K.; Aitken, A., Eds.; Pergamon-Elsevier: Oxford, 2008; Vol. 8, pp 1–116 (Chapter 8.01).
   Google Scholar
  (b) Elnagdi, M. H.; Al-Awadi, N. A. Abdelhamid, I. A. Recent Developments in Pyridazine and Condensed Pyridazine Synthesis. Adv. Heterocycl. Chem. 2009, 97, 1–43.
   Google Scholar
• (a) Svete, J. Synthesis of Functionalized Compounds Containing Pyridazine and Related Moieties. J. Heterocyclic Chem. 2005, 42, 361–373. DOI: 10.1002/jhet.5570420303.
   Web of Science ®Google Scholar
  (b) Wermuth, C. G. Are Pyridazines Privileged Structures? Med. Chem. Commun. 2011, 2, 935–941. DOI: 10.1039/C1MD00074H.
   Web of Science ®Google Scholar
  (c) Kodama, T.; Sasaki, I.; Sugimura, T. Synthesis of Pyridazine Derivatives via Aza-Diels–Alder Reactions of 1,2,3-Triazine Derivatives and 1-Propynylamines. J. Org. Chem. 2021, 86, 8926–8932. DOI: 10.1021/acs.joc.1c00851.
   Web of Science ®Google Scholar
• Sergeev, P. G.; Nenajdenko, V. G. Recent Advances in the Chemistry of Pyridazine − An Important Representative of Six-Membered Nitrogen Heterocycles. Russ. Chem. Rev. 2020, 89, 393–429. DOI: 10.1070/RCR4922.
   Web of Science ®Google Scholar
• (a) Semeraro, C.; Dorigotti, L.; Banfi, S.; Carpi, C. Pharmacological Studies on Cadralazine: A New Antihypertensive Vasodilator Drug. J. Cardiovasc. Pharmacol. 1981, 3, 455–467.
   PubMed Web of Science ®Google Scholar
  (b) Biziere, K.; Worms, P.; Kan, J.; Mandel, P.; Garattini, S.; Roncucci, R. Minaprine, a New Drug with Antidepressant Properties. Drugs Exp. Clin. Res. 1984, 11, 831–840.
   Google Scholar
  (c) Salvadeo, A.; Villa, G.; Segagni, S.; Piazza, V.; Picardi, L.; Romano, M.; Parini, J. Cadralazine, a new vasodilator, in Addition to a Beta-Blocker for Long-Term Treatment of Hypertension. Arzneim. Forsch. 1985, 35, 623–625.
   PubMed Web of Science ®Google Scholar
  (d) Cohn, J. N.; Johnson, G.; Ziesche, S.; Cobb, F.; Francis, G.; Tristani, F.; Smith, R.; Dunkman, W. B.; Loeb, H.; Wong, M. A Comparison of Enalapril with Hydralazine-Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure. N Engl. J. Med. 1991, 325, 303–310.
   PubMed Web of Science ®Google Scholar
  (e) Asif, M. Some Recent Approaches of Biologically Active Substituted Pyridazine and Phthalazine Drugs. Curr. Med. Chem. 2012, 19, 2984–2991. DOI: 10.2174/092986712800672139.
   PubMed Web of Science ®Google Scholar
  (f) El-Sayed, A.; Abd-Elshafy, D. Synthesis of Some New Pyridazine Derivatives for anti-HAV Evaluation. Molecules 2017, 22, 148. DOI: 10.3390/molecules22010148.
   Web of Science ®Google Scholar
• (a) Asif, M.; Singh, A.; Ratnakar, L. Antimicrobial Agents: Brief Study of Pyridazine Derivatives against Some Phathogenic Microrganisms. J. Pharm. Res. 2011, 4, 664–667.
   Google Scholar
  (b) Abed, H. B.; Mammoliti, O.; Bande, O.; Lommen, G. V.; Herdewijn, P. Strategy for the Synthesis of Pyridazine Heterocycles and Their Derivatives. J Org. Chem. 2013, 78, 7845–7858.
   PubMed Web of Science ®Google Scholar
  (c) Asif, M. The Anticancer Potential of Various Substituted Pyridazines and Related Compounds. IJAC. 2014, 2, 148–161. DOI: 10.14419/ijac.v2i2.2661.
   Google Scholar
  (d) Asif, M. The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2 Synthase. J. Chem. 2014, 2014, 1–16. DOI: 10.1155/2014/703238.
   Web of Science ®Google Scholar
• (a) Trofimov, B. A.; Mikhaleva, A. I.; Schmidt, E. Y.; Sobenina, L. N. Chemistry of Pyrroles; CRC Press: Boca Raton, USA, 2015.
   Google Scholar
  (b) Lopchuk, J. M. Five-Membered Ring Systems: Pyrroles and Benzo Analogs. In Progress in Heterocyclic Chemistry; Gribble, G. W.; Joule, J. A., Eds; Elsevier: Oxford, UK, 2016; Vol. 28, pp 165–218 (Chapter 5.2).
   Google Scholar
• (a) Bhardwaj, V.; Gumber, D.; Abbot, V.; Dhiman, S.; Sharma, P. Pyrrole: A Resourceful Small Molecule in Key Medicinal Hetero-Aromatics. RSC Adv. 2015, 5, 15233–15266. DOI: 10.1039/C4RA15710A.
   Web of Science ®Google Scholar
  (b) Kaur, R.; Rani, V.; Abbot, V.; Kapoor, Y.; Konar, D.; Kumar, K. Recent Synthetic and Medicinal Perspectives of Pyrroles: An Overview. J. Pharm. Chem. Chem. Sci. 2017, 1, 17–32.
   Google Scholar
• Khajuria, R.; Dham, S.; Kapoor, K. K. Active Methylenes in the Synthesis of a Pyrrole Motif: An Imperative Structural Unit of Pharmaceuticals, Natural Products and Optoelectronic Materials. RSC Adv. 2016, 6, 37039–37066. DOI: 10.1039/C6RA03411J.
   Web of Science ®Google Scholar
• (a) Molvi, K. I.; Haque, N.; Awen, B. Z. S.; Zameeruddin, M. Synthesis of Spiro Compounds as Medicinal Agents; New Opportunities for Drug Design and Discovery. Part I: A Review. World J. Pharm. Pharm. Sci. 2014, 3, 536–563.
   Google Scholar
  (b) Zheng, Y.; Tice, C. M.; Singh, S. B. The Use of Spirocyclic Scaffolds in Drug Discovery. Bioorg. Med. Chem. Lett. 2014, 24, 3673–3682.
   PubMed Web of Science ®Google Scholar
  (c) Santos, M. M. M. Recent Advances in the Synthesis of Biologically Active Spirooxindoles. Tetrahedron 2014, 70, 9735–9757. DOI: 10.1016/j.tet.2014.08.005.
   Web of Science ®Google Scholar
  (d) Subba Reddy, B. V.; Gopal Reddy, S.; Durgaprasad, M.; Bhadra, M. P.; Sridhar, B. Domino Prins/Pinacol Reaction for the Stereoselective Synthesis of Spiro-[Pyran-4,4′-Quinoline]-2′,3′-Dione Derivatives. Org. Biomol. Chem. 2015, 13, 8729–8733. DOI: 10.1039/C5OB01077B.
   PubMed Web of Science ®Google Scholar
  (e) Kotha, S.; Panguluri, N. R.; Ali, R. Design and Synthesis of Spirocycles. Eur. J. Org. Chem. 2017, 2017, 5316–5342. DOI: 10.1002/ejoc.201700439.
   Web of Science ®Google Scholar
  (f) Vacala, T. L.; Carlson, P. R.; Arreola-Hester, A.; Williams, C. G.; Makhoul, E. W.; Vadola, P. A. Gold-Catalyzed Dearomative Spirocyclization of N-Aryl Alkynamides for the Synthesis of Spirolactams. J. Org. Chem. 2018, 83, 1493–1501.
   PubMed Web of Science ®Google Scholar
• (a) Richie, T. J.; Macdonald, S. J. F. The Impact of Aromatic Ring Count on Compound Developability – Are Too Many Aromatic Rings a Liability in Drug Design? Drug Disc. Today. 2009, 14, 1011–1020. DOI: 10.1016/j.drudis.2009.07.014.
   PubMed Web of Science ®Google Scholar
  (b) Aldeghi, M.; Malhotra, S.; Selwood, D. L.; Chan, A. W. E. Two– and Three–Dimensional Rings in Drugs. Chem. Biol. Drug Des. 2014, 83, 450–461.
   PubMed Web of Science ®Google Scholar
  (c) Zheng, Y.; Tice, C. M.; Singh, S. B. The Use of Spirocyclic Scaffolds in Drug Discovery. Bioorg. Med. Chem. Lett. 2014, 24, 3673–3682.
   PubMed Web of Science ®Google Scholar
• (a) Claire, M.; Faraj, H.; Grassy, G.; Aumelas, A.; Rondot, A.; Auzou, G. Synthesis of New 11.beta.-Substituted Spirolactone Derivatives. Relationship with Affinity for Mineralocorticoid and Glucocorticoid Receptors. J. Med. Chem. 1993, 36, 2404–2407.
   PubMed Web of Science ®Google Scholar
  (b) Lewis, E. J.; Hunsicker, L.,G.; Clarke, W. R.; Berl, T.; Pohl, M. A.; Lewis, J. B.; Ritz, E.; Atkins, R. C.; Rohde, R.; Raz, I. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes. N Engl. J. Med. 2001, 345, 851–860. DOI: 10.1056/NEJMoa011303.
   PubMed Web of Science ®Google Scholar
  (c) Kuhl, H. Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric. 2005, 8, 3–63. DOI: 10.1080/13697130500148875.
   PubMed Web of Science ®Google Scholar
  (d) Massie, B. M.; I-PRESERVE Investigators; Carson, P. E.; McMurray, J. J.; Komajda, M.; McKelvie, R.; Zile, M. R.; Anderson, S.; Donovan, M.; Iverson, E.; Staiger, C.; Ptaszynska, A. Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. N Engl. J. Med. 2008, 359, 2456–2467.
   PubMed Web of Science ®Google Scholar
  (e) Friedman, A. J. Spironolactone for Adult Female Acne. Cutis. 2015, 96, 216–217.
   PubMed Web of Science ®Google Scholar
  (f) Wiesinger, H.; Berse, M.; Klein, S.; Gschwend, S.; Hochel, J.; Zollmann, F. S.; Schutt, B. Pharmacokinetic Interaction Between the CYP3A4 Inhibitor Ketoconazole and the Hormone Drospirenone in Combination with Ethinylestradiol or Estradiol. Br. J. Clin. Pharmacol. 2015, 80, 1399–1410. DOI: 10.1111/bcp.12745.
   PubMed Web of Science ®Google Scholar
• Yang, K.; Fu, L. Mechanisms of Resistance to BCR–ABL TKIs and the Therapeutic Strategies: A Review. Crit. Rev. Oncol. Hemat. 2015, 93, 277–292. DOI: 10.1016/j.critrevonc.2014.11.001.
   PubMed Web of Science ®Google Scholar
• (a) Chen, Z.; Kim, S. H.; Barbosa, S. A.; Huynh, T.; Tortolani, D. R.; Leavitt, K. J.; Wei, D. D.; Manne, V.; Ricca, C. S.; Gullo-Brown, J.; Poss  et al. Pyrrolopyridazine MEK Inhibitors. Bioorg. Med. Chem. Lett. 2006, 16, 628–632. (b) Fox, B. M.; Iio, K.; Li, K.; Choi, R.; Inaba, T.; Jackson, S.; Sagawa, S.; Shan, B.; Tanaka, M.; Yoshida, A.; Kayser, F.Discovery of Pyrrolopyridazines as Novel DGAT1 Inhibitors. Bioorg. Med. Chem. Lett. 2010, 20, 6030–6033. (c) Hynes, J.; Wu, H.; Kempson, J.; Duan, J. J. W.; Lu, Z.; Jiang, B.; Stachura, S.; Tokarski, J. S.; Sack, J. S.; Khan, J. A.; et al. Discovery of Potent and Efficacious Pyrrolopyridazines as Dual JAK1/3 Inhibitors. Bioorg. Med. Chem. Lett. 2017, 27, 3101–3106. (d) Plieva, A. T. Methods for the Synthesis of Pyrrolo[1,2-b]Pyridazine and Pyrrolo[1,2-b]Cinnoline Derivatives. Chem. Heterocycl. Comp. 2019, 55, 199–201. DOI: 10.1007/s10593-019-02441-5. (e) Popovici, L.; Amarandi, R. M.; Mangalagiu, I. I.; Mangalagiu, V.; Danac, R. Synthesis, Molecular Modelling and Anticancer Evaluation of New Pyrrolo[1,2-b]Pyridazine and Pyrrolo-[2,1-a]Phthalazine Derivatives. J. Enzyme Inhib. Med. Chem. 2019, 34, 230–243. DOI: 10.1080/14756366.2018.1550085. (f) Chang, S. M.; Jain, V.; Chen, T. L.; Patel, A. S.; Pidugu, H. B.; Lin, Y. W.; Wu, M. H.; Huang, J. R.; Wu, H. C.; Shah, A.; et al. Design and Synthesis of 1,2-Bis(Hydroxymethyl)-Pyrrolo[2,1-a]Phthalazine Hybrids as Potent Anticancer Agents That Inhibit Angiogenesis and Induce DNA Interstrand Cross-Links. J. Med. Chem. 2019, 62, 2404–2418.
   PubMed Web of Science ®Google Scholar
• (a) Mitsumori, T.; Bendikov, M.; Sedo, J.; Wudl, F. Synthesis and Properties of Novel Highly Fluorescent Pyrrolopyridazine Derivatives. Chem. Mater. 2003, 15, 3759–3768. DOI: 10.1021/cm0340532.
   Web of Science ®Google Scholar
  (b) Mitsumori, T.; Craig, I. M.; Martini, I. B.; Schwartz, B. J.; Wudl, F. Synthesis and Color Tuning Properties of Blue Highly Fluorescent Vinyl Polymers Containing a Pendant Pyrrolopyridazine. Macromolecules 2005, 38, 4698–4704. DOI: 10.1021/ma048091y.
   Web of Science ®Google Scholar
  (c) Swamy, K. M. K.; Park, M. S.; Han, S. J.; Kim, S. K.; Kim, J. H.; Lee, C.; Bang, H.; Kim, Y.; Kim, S. J.; Yoon, J. New Pyrrolopyridazine Derivatives as Blue Organic Luminophors. Tetrahedron 2005, 61, 10227–10234. DOI: 10.1016/j.tet.2005.08.038.
   Web of Science ®Google Scholar
  (d) Zbancioc, G. N. Mangalagiu, I. I. Microwave-Assisted Synthesis of Highly Fluorescent Pyrrolopyridazine Derivatives. Synlett 2006, 804–806.
   Web of Science ®Google Scholar
• (a) Vessally, E. A. A New Avenue to the Synthesis of Highly Substituted Pyrroles: synthesis from N-Propargylamines. RSC Adv. 2016, 6, 18619–18631. DOI: 10.1039/C5RA20706A.
   Web of Science ®Google Scholar
  (b) Vessally, E.; Hosseinian, A.; Edjlali, L.; Bekhradnia, A.; Esrafili, M. D. New Page to Access Pyridine Derivatives: Synthesis from N-Propargylamines. RSC Adv. 2016, 6, 71662–71675. DOI: 10.1039/C6RA08720E.
   Web of Science ®Google Scholar
  (c) Arshadi, S.; Vessally, E.; Edjlali, L.; Ghorbani-Kalhor, E.; Hosseinzadeh-Khanmiri, R. N-Propargylic β-Enaminocarbonyls: Powerful and Versatile Building Blocks in Organic Synthesis. RSC Adv. 2017, 7, 13198–13211. DOI: 10.1039/C7RA00746A.
   Web of Science ®Google Scholar
• (a) Yilmaz, E. S.; Zora, M. A New Strategy for the Synthesis of 4-Propargyl-Substituted 1H-Pyrroles from N-(5-Phenyl-2,4-Pentadiynyl) β-Enaminones. ChemistrySelect 2019, 4, 11043–11047. DOI: 10.1002/slct.201902759.
   Web of Science ®Google Scholar
  (b) Kanova, N.; Dundar, B. A.; Kelgokmen, Y.; Zora, M. One-Pot Synthesis of 2-Acetyl-1H-Pyrroles from N-Propargylic β-Enaminones via Intermediacy of 1,4-Oxazepines. J. Org. Chem. 2021, 86, 6289–6304.
   PubMed Web of Science ®Google Scholar
• Korkmaz, E.; Zora, M. Synthesis of 3-[(4-Nitrophenyl)Thio]-Substituted 4-Methylene-1-Pyrrolines from N-Propargylic β-Enaminones. J. Org. Chem. 2020, 85, 4937–4950. DOI: 10.1021/acs.joc.0c00109.
   PubMed Web of Science ®Google Scholar
• (a) Karabiyikoglu, S.; Kelgokmen, Y.; Zora, M. Facile Synthesis of Iodopyridines from N-Propargylic β-Enaminones via Iodine-Mediated Electrophilic Cyclization. Tetrahedron 2015, 71, 4324–4333. DOI: 10.1016/j.tet.2015.04.070.
   Web of Science ®Google Scholar
  (b) Karadeniz, E.; Zora, M.; Kılıcaslan, N. Z. Facile Synthesis of Aryl-Substituted Pyridines via Suzuki-Miyaura Approach. Tetrahedron 2015, 71, 8943–8952. DOI: 10.1016/j.tet.2015.09.063.
   Web of Science ®Google Scholar
  (c) Kelgokmen, Y.; Zora, M. Facile Synthesis of Heavily-Substituted Alkynylpyridines via a Sonogashira Approach. RSC Adv. 2016, 6, 4608–4621. DOI: 10.1039/C5RA21701F.
   Web of Science ®Google Scholar
  (d) Karadeniz, E.; Zora, M. One-Pot Synthesis of 2-Ferrocenyl-Substituted Pyridines. Tetrahedron Lett. 2016, 57, 4930–4934. DOI: 10.1016/j.tetlet.2016.09.080.
   Web of Science ®Google Scholar
  (e) Kelgokmen, Y.; Zora, M. A New Strategy for the Synthesis of Pyridines from N-Propargylic β-Enaminothiones. Org. Biomol. Chem. 2019, 17, 2529–2541.
   PubMed Web of Science ®Google Scholar
• (a) Kelgokmen, Y.; Cayan, Y.; Zora, M. Zinc Chloride Mediated Synthesis of 1,4-Oxazepines from N-Propargylic β-Enaminones. Eur. J. Org. Chem. 2017, 2017, 7167–7178. DOI: 10.1002/ejoc.201701433.
   Web of Science ®Google Scholar
  (b) Zora, M.; Dikmen, E.; Kelgokmen, Y. One-Pot Synthesis of Iodine-Substituted 1,4-Oxazepines. Tetrahedron Lett. 2018, 59, 823–827. DOI: 10.1016/j.tetlet.2018.01.048.
   Web of Science ®Google Scholar
  (c) Ibis, O.; Zora, M. A Facile Synthesis of 6-Chloro-2-Methylene-2,3-Dihydro-1,4-Oxazepines from N-Propargylic β-Enaminones. Tetrahedron 2020, 76, 131650. DOI: 10.1016/j.tet.2020.131650.
   Web of Science ®Google Scholar
  (d) Kelgokmen, Y.; Korkmaz, E.; Zora, M. A Facile Synthesis of 6-[(4-Nitrophenyl)Thio]-Substituted 2-Methylene-2,3-Dihydro-1,4-Oxazepines from N-Propargylic β-Enaminones. Synth. Commun. 2021, 51, 541–552. DOI: 10.1080/00397911.2020.1837171.
   Web of Science ®Google Scholar
• (a) Kelgokmen, Y.; Zora, M. Synthesis of 1,4-Thiazepines. J. Org. Chem. 2018, 83, 8376–8389.
   PubMed Web of Science ®Google Scholar
  (b) Yilmaz, E. S.; Zora, M. A Facile One-Pot Synthesis of 2-(Prop-2-yn-1-Ylidene)-2,3-Dihydro-1,4-Thiazepines. Synth. Commun. 2021, 51, 709–719. DOI: 10.1080/00397911.2020.1850795.
   Web of Science ®Google Scholar
• Karadeniz, E.; Zora, M. Synthesis of 1-Azaspiro[4.5]Deca-1,3-Dienes from N-Propargylic β-Enaminones in Basic Medium. Synthesis 2019, 51, 2157–2170. DOI: 10.1055/s-0037-1611723.
   Web of Science ®Google Scholar
• Karadeniz, E.; Zora, M. One-Pot Synthesis of Spiro-2H-Pyrroles from N-Propargylic β-Enaminones. Synlett 2019, 30, 1231–1236. DOI: 10.1055/s-0037-1611816.
   Web of Science ®Google Scholar
• Karadeniz, E.; Kelgokmen, Y.; Zora, M. A New Approach for the Synthesis of Spiro and Gem-Dimethyl-Substituted 1,4-Oxazepines from N-Propargylic β-Enaminones. J. Heterocyclic Chem. 2021, 58, 466–477. DOI: 10.1002/jhet.4183.
   Web of Science ®Google Scholar
• (a) Gao, Q.; Zhu, Y.; Lian, M.; Liu, M.; Yuan, J.; Yin, G.; Wu, A. Unexpected C − C Bond Cleavage: A Route to 3,6-Diarylpyridazines and 6-Arylpyridazin-3-Ones from 1,3-Dicarbonyl Compounds and Methyl Ketones. J. Org. Chem. 2012, 77, 9865–9870.
   PubMed Web of Science ®Google Scholar
  (b) Xin, L.; Xue, J.; Lei, G.; Qiao, J. Efficient near-Infrared-Emitting Cationic Iridium Complexes Based on Highly Conjugated Cyclometalated Benzo[g]Phthalazine Derivatives. RSC Adv. 2015, 5, 42354–42361. DOI: 10.1039/C5RA04511H.
   Web of Science ®Google Scholar
  (c) Baumgartner, K.; Kirschbaum, T.; Krutzek, F.; Dreuw, A.; Rominger, F.; Mastalerz, M. K-Region-Extended [c]-Heteroannulated Pyrenes.  Chem. Eur. J. 2017, 23, 17817–17822.
   Google Scholar
• (a) Zhang, F.; Wu, D.; Xu, Y.; Feng, X. Thiophene-Based Conjugated Oligomers for Organic Solar Cells. J. Mater. Chem. 2011, 21, 17590–17600. DOI: 10.1039/c1jm12801a.
   Web of Science ®Google Scholar
  (b) Gramec, D.; Masic, L. P.; Dolenc, M. S. Bioactivation Potential of Thiophene-Containing Drugs. Chem. Res. Toxicol. 2014, 27, 1344–1358.
   PubMed Web of Science ®Google Scholar
  (c) Smith, Z. C.; Meyer, D. M.; Simon, M. G.; Staii, C.; Shukla, D.; Thomas, S. W. III, Thiophene-Based Conjugated Polymers with Photolabile Solubilizing Side Chains. Macromolecules 2015, 48, 959–966. DOI: 10.1021/ma502289n.
   Web of Science ®Google Scholar
• (a) Hernandes, M. Z.; Cavalcanti, S. M. T.; Moreira, D. R. M.; de Azevedo Junior, W. F.; Leite, A. C. L. Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design. Curr. Drug Targets. 2010, 11, 303–314. DOI: 10.2174/138945010790711996.
   PubMed Web of Science ®Google Scholar
  (b) Wilcken, R.; Zimmermann, M. O.; Lange, A.; Joerger, A. C.; Boeckler, F. M. Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology. J. Med. Chem. 2013, 56, 1363–1388. DOI: 10.1021/jm3012068.
   PubMed Web of Science ®Google Scholar
  (c) Shinada, N. K.; de Brevern, A. G.; Schmidtke, P. Halogens in Protein–Ligand Binding Mechanism: A Structural Perspective. J. Med. Chem. 2019, 62, 9341–9356.
   PubMed Web of Science ®Google Scholar
• (a) Filler, R.; Saha, R. Fluorine in Medicinal Chemistry: A Century of Progress and a 60-Year Retrospective of Selected Highlights. Future Med. Chem. 2009, 1, 777–791. DOI: 10.4155/fmc.09.65.
   PubMed Web of Science ®Google Scholar
  (b) Wang, J.; Sanchez-Rosello, M.; Acena, J. L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; Liu, H. Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011). Chem. Rev. 2014, 114, 2432–2506. DOI: 10.1021/cr4002879.
   PubMed Web of Science ®Google Scholar
  (c) Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.; Meanwell, N. A. Applications of Fluorine in Medicinal Chemistry. J. Med. Chem. 2015, 58, 8315–8359.
   PubMed Web of Science ®Google Scholar